Patent ID: 11958869
Assignee: CITY UNIVERSITY OF HONG KONG
Field: Organic fine chemistry (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 4:
5. The method of claim 3, wherein the malignant neoplasm is selected from the group consisting of carcinoma, sarcoma, lymphoma, leukemia, germ cell tumor, blastoma, brain cancer, medulloblastoma, glioma, head and neck cancer, oral cancer, laryngeal cancer, nasopharynx cancer, thyroid cancer, myeloid neoplasm, lung cancer, non-small cell lung cancer, small cell lung cancer, mesothelioma, hepatocellular carcinoma, lymphoid neoplasm, bone cancer, Ewing sarcoma, osteosarcoma, skeletal cancer, muscle cancer, rhabdomyo sarcoma, skin cancer, basal cell carcinoma, squamous cell carcinoma, connective tissue cancer, fibrosarcoma, cartilage cancer, chondrosarcoma, nerve tissue cancer, neuroblastoma, gastric cancer, esophageal cancer, pancreatic cancer, kidney cancer, bladder cancer, prostate cancer, breast cancer, triple-negative breast cancer, testicular cancer, ovarian cancer, uterine cancer, fallopian tube cancer, and cervical cancer.